Evaluation of E-learning on Suicide Prevention for Professionals in a Detention Context

by palligoelme@gmail.com | Jul 23, 2025 | Clinical Trials

​ Conditions: Suicide Prevention Interventions: Behavioral: E-learning Sponsors: University Ghent Recruiting Conditions: Suicide Prevention Interventions: Behavioral: E-learning Sponsors: University Ghent Recruiting 

Artificial Intelligence to Detect Missed Root Canals in Previously Treated Lower Back Teeth Using 3D Dental Imaging (CBCT)

by palligoelme@gmail.com | Jul 22, 2025 | Clinical Trials

​ Conditions: Presence of Missed Canals; Morphological Variation Interventions: Procedure: Root Canal Retreatment Sponsors: Future University in Egypt Enrolling by invitation Conditions: Presence of Missed Canals; Morphological Variation Interventions: Procedure: Root...

Ice Cream Enriched With Cimarrón Bean Extrudate and Cardiovascular Risk in Adults

by palligoelme@gmail.com | Jul 22, 2025 | Clinical Trials

​ Conditions: Cardiovascular Risk Factors; Insulin Resistance; Overweight (BMI > 25) Interventions: Dietary Supplement: Functional Ice Cream with Cimarrón Bean Extrudate; Dietary Supplement: Placebo Ice Cream Sponsors: University of Talca; Centro de Estudios en...

Comparing the Efficacy of Core Stability Exercises and Pilates in Fibromyalgia Management: A Randomized Controlled Trial

by palligoelme@gmail.com | Jul 22, 2025 | Clinical Trials

​ Conditions: Fibromyositis-Fibromyalgia Syndrome Interventions: Other: Core Stability Exercises; Other: Pilates: Sponsors: Al-Zaytoonah University of Jordan Not yet recruiting Conditions: Fibromyositis-Fibromyalgia Syndrome Interventions: Other: Core Stability...

CAR19BCMA CAR-T Cells for the Treatment of R/R Plasma Cell Neoplasms

by palligoelme@gmail.com | Jul 22, 2025 | Clinical Trials

​ Conditions: Relapsed or Refractory Plasma Cell Neoplasms Interventions: Other: CAR19BCMA-T cells Sponsors: Chinese PLA General Hospital Not yet recruiting Conditions: Relapsed or Refractory Plasma Cell Neoplasms Interventions: Other: CAR19BCMA-T cells Sponsors:...

A Study Comparing BMS-986504 in Combination With Nab-paclitaxel and Gemcitabine Versus Placebo in Combination With Nab-paclitaxel and Gemcitabine in Participants With Untreated Metastatic Pancreatic Ductal Adenocarcinoma With Homozygous MTAP Deletion (MountainTAP-30)

by palligoelme@gmail.com | Jul 21, 2025 | Clinical Trials

​ Conditions: Pancreatic Ductal Adenocarcinoma Interventions: Drug: BMS-986504; Drug: Gemcitabine; Drug: Nab-paclitaxel; Drug: Placebo Sponsors: Bristol-Myers Squibb Not yet recruiting Conditions: Pancreatic Ductal Adenocarcinoma Interventions: Drug: BMS-986504; Drug:...